Secondary analysis of the NEWPRIDE trial in 69 unmedicated remitted recurrent MDD patients: preventive cognitive therapy vs waiting list changed anhedonia, which mediated lower dysfunctional attitudes; both changes predicted 18-month relapse in PCT recipients.
Secondary analysisn = 69
Angeles-Valdez et al. The role of cognitive and affective changes in preventing depressive relapse: A network analysis approach to understanding the mechanisms of preventive cognitive therapy